Literature DB >> 17854444

Early and late onset Clostridium difficile-associated colitis following liver transplantation.

Jeffrey B Albright1, Hugo Bonatti, Julio Mendez, David Kramer, John Stauffer, Ronald Hinder, Jaime A Michel, Rolland C Dickson, Chris Hughes, Justin Nguyen, Heidi Chua, Walter Hellinger.   

Abstract

Clostridium difficile colitis (CDC) remains a serious and common complication after liver transplantation (LT). Four hundred and sixty-seven consecutive LTs in 402 individuals were performed between 1998 and 2001 at our center. Standard immunosuppression consisted of tacrolimus, mycophenolate, and steroids. CD toxins A and B were detected by using a rapid immunoassay or enzyme immunoassay. CDC was diagnosed in 32 patients (5-1999 days post-LT), with 93.8% (30/32) of patients developing CDC during the first year post-LT; three individuals had CDC more than 3 years post-LT, one of which also had early CDC. All patients presented with abdominal pain and watery diarrhea. Patients who developed CDC within 1-year post-LT were significantly more likely to have a hemorrhagic, biliary, or infectious complication. Patients who developed CDC within 28 days post-LT had a significantly higher model end-stage liver disease score. Treatment consisted of fluid and electrolyte replacement and metronidazole and no patients developed toxic megacolon, required colonic resection, or died from CDC. CDC represents a potentially severe complication following LT. Most cases occur early post-LT. Development of a hemorrhagic, biliary, or infectious complication is associated with the development of CDC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854444     DOI: 10.1111/j.1432-2277.2007.00530.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  29 in total

1.  Fulminant Clostridium difficile colitis in a post-liver transplant patient.

Authors:  Maximilian Lee; Andrew A Shelton; Waldo L Concepcion; Clark A Bonham; Tami J Daugherty
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

Review 2.  Update and actual trends on bacterial infections following liver transplantation.

Authors:  Jose Luis del Pozo
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 3.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

4.  Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.

Authors:  Dana S Clutter; Yanina Dubrovskaya; Man Yee Merl; Lewis Teperman; Robert Press; Amar Safdar
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

5.  Repeated Clostridium difficile infection after living donor liver transplantation.

Authors:  Kyohei Abe; Hiroaki Shiba; Kenei Furukawa; Taro Sakamoto; Yuichi Ishida; Katsuhiko Yanaga
Journal:  Clin J Gastroenterol       Date:  2018-03-01

6.  Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Shahryar Ahmad; Nilay Kumar; Gagan Kumar; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

Review 7.  Clostridium difficile Infection in Children: Current State and Unanswered Questions.

Authors:  Pranita D Tamma; Thomas J Sandora
Journal:  J Pediatric Infect Dis Soc       Date:  2012-07-25       Impact factor: 3.164

Review 8.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Carolyn D Alonso; Mini Kamboj
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

10.  Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Authors:  Yao-Wen Cheng; Emmalee Phelps; Vincent Ganapini; Noor Khan; Fangqian Ouyang; Huiping Xu; Sahil Khanna; Raseen Tariq; Rachel J Friedman-Moraco; Michael H Woodworth; Tanvi Dhere; Colleen S Kraft; Dina Kao; Justin Smith; Lien Le; Najwa El-Nachef; Nirmal Kaur; Sree Kowsika; Adam Ehrlich; Michael Smith; Nasia Safdar; Elizabeth Ann Misch; Jessica R Allegretti; Ann Flynn; Zain Kassam; Asif Sharfuddin; Raj Vuppalanchi; Monika Fischer
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.